Conceptio › Archive › Europe PMC
Europe PMCopen access

A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)

Jagannath V et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
childrensafety
Safety, Children, Immunogenicity, Pneumococcal Conjugate Vaccine, V116
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 478551
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.